Bouchelouche P N, Reimert C, Bendtzen K
Department of Clinical Chemistry and Medicine C, Herlev Hospital, University of Copenhagen, Denmark.
Leukemia. 1988 Oct;2(10):691-6.
Changes in the concentration of cytosolic free calcium ((Ca2+)i) in response to purified blood monocyte IL-1 and human rIL-1 alpha and rIL-1 beta (17.5 kDa) were measured in murine L-M fibroblasts and in human foreskin fibroblasts using the fluorescent Ca2+ indicator, fura-2. In L-M fibroblasts, each of these IL-1 species, but not a recombinant 24-kDa precursor of the predominant IL-1 beta, produced a prompt, dose-related, and transient increase in (Ca2+)i. The effect was smaller but not eliminated when the cells were stimulated in EGTA-containing calcium, suggesting that the rise in (Ca2+)i was due to influx from both intracellular and extracellular Ca2+ pools. In human fibroblasts, however, the (Ca2+)i increased gradually, reaching a maximum after 1 hr of incubation with IL-1 and returning slowly to near basal levels in the following 2 hr. In contrast to the L-M cells, this accumulation of Ca2+ was abolished by EGTA, suggesting that in human fibroblasts, Ca2+ is mobilized solely from the extracellular space. Addition of the Ca2+ channel blockers verapamil and nifedipine was ineffective. IL-1 alpha and IL-1 beta both induced a dose-related increase in prostaglandin E2, but only in the human fibroblasts. These findings indicate that an increase in (Ca2+)i may be an important second mediator by which IL-1 initiates cell activation, but the signal may differ between cells.
使用荧光钙指示剂fura - 2,在小鼠L - M成纤维细胞和人包皮成纤维细胞中测量了对纯化的血液单核细胞IL - 1以及人重组IL - 1α和rIL - 1β(17.5 kDa)的反应中胞质游离钙((Ca2 +)i)浓度的变化。在L - M成纤维细胞中,这些IL - 1种类中的每一种,而非主要IL - 1β的重组24 kDa前体,均能引起(Ca2 +)i迅速、剂量相关且短暂的增加。当细胞在含EGTA的钙中受到刺激时,这种效应较小但并未消除,这表明(Ca2 +)i的升高是由于细胞内和细胞外钙库的流入。然而,在人成纤维细胞中,(Ca2 +)i逐渐增加,在与IL - 1孵育1小时后达到最大值,并在接下来的2小时内缓慢恢复到接近基础水平。与L - M细胞不同,EGTA消除了这种钙的积累,这表明在人成纤维细胞中,钙仅从细胞外空间动员。添加钙通道阻滞剂维拉帕米和硝苯地平无效。IL - 1α和IL - 1β均诱导前列腺素E2剂量相关的增加,但仅在人成纤维细胞中。这些发现表明,(Ca2 +)i的增加可能是IL - 1启动细胞活化的重要第二介质,但细胞间的信号可能不同。